Acts Online
GT Shield

South African Institute for Drug-Free Sport Act, 1997 (Act No. 14 of 1997)

1. Definitions and Interpretation

 

(1) In this Act, unless the context indicates otherwise—

 

"Anti-Doping Organisation"

means an Anti-Doping Organisation as defined in Appendix 1;

 

"Appeal Board"

means the Anti-Doping Appeal Board established by section 17;

 

"Appendix 1"

means Appendix 1 to the Code;

 

"athlete"

means an athlete as defined in Appendix 1;

 

"Code"

means the World Anti-Doping Code adopted by the Foundation Board of WADA on 5 March 2003 at Copenhagen, Denmark as amended from time to time;

 

"Department"

means the national department responsible for sport;

 

"doping"

means doping as defined in Article 1 of the Code;

 

"doping control"

means doping control as defined in Appendix 1;

 

"Institute"

means the South African Institute for Drug-Free Sport, established by section 2;

 

"International-Level Athlete"

means an International-Level Athlete as defined in Appendix 1;

 

"International Olympic Committee"

means the organisation of that name with its headquarters in Lausanne, Switzerland, under the auspices of which the Olympic Games are conducted;

 

"international sports federation"

means any group of national sports bodies involved in the overseeing and co-operation of the playing and administration of any particular sport at international level;

 

"International Standard"

means International Standard as defined in Appendix 1;

 

"Minister"

means the Minister responsible for sport;

 

"National Anti-Doping Organisation (NADO)"

means the National Anti-Doping Organisation as defined in Appendix 1;

 

"national sports federation"

means any number of people involved in the overseeing and co-ordination of the playing and administration of any particular sport in any particular country;

 

"person"

means a natural person or an organisation or other entity;

 

"Prohibited List"

means the Prohibited List as defined in Appendix 1;

 

"prohibited substance"

means a Prohibited Substance as defined in Appendix 1;

 

"public entity"

means a public entity as defined in section 1 of the Public Finance Management Act, 1999 (Act No. 1 of 1999);

 

"Public Finance Management Act"

means the Public Finance Management Act, 1999 (Act No. 1 of 1999);

 

"Results Management"

means Results Management as defined in Appendix 1;

 

"testing"

means testing as defined in Appendix 1;

 

"the Sports Confederation"

means the Sports Confederation as defined in section 1 of the National Sport and Recreation Act, 1998 (Act No. 110 of 1998);

 

"Therapeutic Use Exemption (TUE)"

means Therapeutic Use Exemption as defined in Appendix 1;

 

"UNESCO Convention"

means the UNESCO (United Nations Educational, Scientific and Cultural Organisation) Convention as defined in Appendix 1;

 

"WADA"

means the World Anti-Doping Agency; and

 

"WADA-accredited laboratory"

means a laboratory accredited by WADA according to the International Standard for Laboratories.

 

(2) When interpreting a provision of this Act, any reasonable interpretation which is consistent with the Code must be preferred over any alternative interpretation which is inconsistent with the Code.

 

[Definitions substituted by section 1 of the The South African Institute for Drug-Free Sport Amendment Act, 2024 (Act No. 33 of 2024), Notice No. 4925, GG50751, dated 4 June 2024 - effective 5 August 2024 per Commencement Notice 2674 of GG51009]